Clinical trial
Impacts of Different ART Regimens on Lipid Metabolism in People Living With Human Immunodeficiency Virus
NCT06019273 is registered in ClinicalTrials.gov with First Affiliated Hospital of Zhejiang University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impacts of Different ART Regimens on Lipid Metabolism in People Living With Human Immunodeficiency Virus
- Lead sponsor
- First Affiliated Hospital of Zhejiang University
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- April 25, 2022
- Completion date
- May 1, 2024
- Enrollment
- 180 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
combined antiretroviral therapy, hiv infection